Target intelligence / Profile preview

ACBD3 antisense RNA 1 (ACBD3-AS1)

Target
ACBD3-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA, Other
01

Overview

ACBD3 antisense RNA 1 (ACBD3-AS1) is a long non-coding RNA that is transcribed from the opposite strand of the ACBD3 gene locus. As an antisense transcript, its primary biological function is thought to be the regulation of the ACBD3 sense mRNA, likely through mechanisms such as hybridization with the sense transcript, modification of chromatin structure, or recruitment of epigenetic modifiers. There is currently no evidence that ACBD3-AS1 functions as a therapeutic target, nor are there characterized drugs, biomarkers, or disease connections directly associated with this transcript[3]. It is an example of the growing class of lncRNAs whose regulatory roles in gene expression are still being elucidated. No known safety concerns are documented, and its therapeutic relevance remains undefined at this time[3].

Other names
RP11-275I14.4
02

Biological functions

Regulation of gene expression (antisense regulation)Possible involvement in epigenetic modification (via DNA methylation)Other
03

Disease associations

Other (no direct disease association found for ACBD3-AS1 specifically)

Beyond the preview

Go deeper on ACBD3 antisense RNA 1 (ACBD3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACBD3 antisense RNA 1 (ACBD3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call